HSBC Knock-Out NVO/ DE000HS3V2P7 /
06.11.2024 18:35:34 | Изменение-0.290 | Бид18:36:28 | Предложение- | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.070EUR | -80.56% | - Величина цены спроса: - |
- Величина цены предложения: - |
Novo Nordisk | 106.5226 - | 31.12.2078 | Call |
Newsfile Corp
28.08
The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire
28.08
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire
28.08
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
GlobeNewswire
27.08
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire
26.08
Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amy...
GlobeNewswire
21.08
ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
GlobeNewswire
14.08
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire
06.08
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire
01.08
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Dire...
GlobeNewswire
11.07
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
GlobeNewswire
11.07
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire
11.07
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница